Levy Itzhak, Katz Jacob, Solter Ester, Samra Zmira, Vidne Bernardo, Birk Einat, Ashkenazi Shai, Dagan Ovadia
Department of Pediatric Infectious Diseases, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel.
Pediatr Infect Dis J. 2005 Aug;24(8):676-9. doi: 10.1097/01.inf.0000172934.98865.14.
Infections of short term, nontunneled, intravascular catheters are often caused by migration of organisms from the insertion site. The aim of this study was to evaluate the effectiveness and safety of a chlorhexidine gluconate-impregnated dressing for the reduction of central venous catheter (CVC) colonization and CVC-associated bloodstream infections in infants and children after cardiac surgery.
This prospective, randomized, controlled study was conducted in the pediatric cardiac intensive care unit of a tertiary care pediatric medical center. Patients 0-18 years of age who were admitted to the pediatric cardiac intensive care unit during a 14-month period and required a CVC for >48 hours were randomized to receive a transparent polyurethane insertion site dressing (control group) or a chlorhexidine gluconate-impregnated sponge (Biopatch) dressing covered by a transparent polyurethane dressing (study group). The main outcome measures were rates of bacterial colonization, rates of CVC-associated bloodstream infections and adverse events.
Seventy-one patients were randomized to the control group and 74 to the study group. There were no significant between group differences in age, sex, Pediatric Risk of Mortality score or cardiac severity score. CVC colonization occurred in 21 control patients (29%) and 11 (14.8%) study patients (P = 0.0446; relative risk, 0.6166; 95% confidence interval, 0.3716-1.023). Bloodstream infection occurred in 3 patients (4.2%) in the control group and 4 patients (5.4%) in the study group. Local redness was noted in 1 control patient and 4 study group patients.
The chlorhexidine gluconate-impregnated sponge is safe and significantly reduces the rates of CVC colonization in infants and children after cardiac surgery.
短期、非隧道式血管内导管感染通常是由微生物从插入部位迁移所致。本研究旨在评估葡萄糖酸氯己定浸渍敷料在降低心脏手术后婴幼儿和儿童中心静脉导管(CVC)定植及CVC相关血流感染方面的有效性和安全性。
本前瞻性、随机、对照研究在一家三级儿科医疗中心的儿科心脏重症监护病房进行。在14个月期间入住儿科心脏重症监护病房且需要CVC超过48小时的0至18岁患者被随机分为两组,分别接受透明聚氨酯插入部位敷料(对照组)或覆盖有透明聚氨酯敷料的葡萄糖酸氯己定浸渍海绵(生物贴片)敷料(研究组)。主要观察指标为细菌定植率、CVC相关血流感染率及不良事件。
71例患者被随机分配至对照组,74例被分配至研究组。两组在年龄、性别、儿科死亡风险评分或心脏严重程度评分方面无显著差异。21例(29%)对照组患者和11例(14.8%)研究组患者发生CVC定植(P = 0.0446;相对风险,0.6166;95%置信区间,0.3716 - 1.023)。对照组3例(4.2%)患者和研究组4例(5.4%)患者发生血流感染。1例对照组患者和4例研究组患者出现局部发红。
葡萄糖酸氯己定浸渍海绵安全且能显著降低心脏手术后婴幼儿和儿童的CVC定植率。